X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Lupin Ltd with TTK HEALTHCARE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LUPIN LTD vs TTK HEALTHCARE - Comparison Results

LUPIN LTD    Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    LUPIN LTD TTK HEALTHCARE LUPIN LTD/
TTK HEALTHCARE
 
P/E (TTM) x 162.6 26.3 617.9% View Chart
P/BV x 3.0 5.8 52.0% View Chart
Dividend Yield % 0.8 0.5 165.8%  

Financials

 LUPIN LTD   TTK HEALTHCARE
EQUITY SHARE DATA
    LUPIN LTD
Mar-17
TTK HEALTHCARE
Mar-14
LUPIN LTD/
TTK HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs1,750663 263.8%   
Low Rs1,384399 346.7%   
Sales per share (Unadj.) Rs387.4535.6 72.3%  
Earnings per share (Unadj.) Rs56.615.9 355.2%  
Cash flow per share (Unadj.) Rs76.820.0 383.7%  
Dividends per share (Unadj.) Rs7.504.00 187.5%  
Dividend yield (eoy) %0.50.8 63.6%  
Book value per share (Unadj.) Rs298.9137.6 217.2%  
Shares outstanding (eoy) m451.587.77 5,811.8%   
Bonus/Rights/Conversions ESOPS--  
Price / Sales ratio x4.01.0 407.8%   
Avg P/E ratio x27.733.3 83.0%  
P/CF ratio (eoy) x20.426.5 76.9%  
Price / Book Value ratio x5.23.9 135.8%  
Dividend payout %13.225.1 52.8%   
Avg Mkt Cap Rs m707,5134,127 17,141.8%   
No. of employees `00016.81.7 983.1%   
Total wages/salary Rs m28,495607 4,697.5%   
Avg. sales/employee Rs Th10,418.32,436.7 427.6%   
Avg. wages/employee Rs Th1,697.0355.2 477.8%   
Avg. net profit/employee Rs Th1,523.072.5 2,099.5%   
INCOME DATA
Net Sales Rs m174,9434,162 4,203.5%  
Other income Rs m1,06561 1,740.4%   
Total revenues Rs m176,0084,223 4,167.9%   
Gross profit Rs m44,931197 22,796.2%  
Depreciation Rs m9,12232 28,777.0%   
Interest Rs m1,52530 5,101.3%   
Profit before tax Rs m35,349197 17,971.0%   
Minority Interest Rs m-720-   
Prior Period Items Rs m830-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m9,78573 13,441.1%   
Profit after tax Rs m25,575124 20,641.3%  
Gross profit margin %25.74.7 542.3%  
Effective tax rate %27.737.0 74.8%   
Net profit margin %14.63.0 491.0%  
BALANCE SHEET DATA
Current assets Rs m119,5421,629 7,339.7%   
Current liabilities Rs m61,2061,058 5,786.2%   
Net working cap to sales %33.313.7 243.1%  
Current ratio x2.01.5 126.8%  
Inventory Days Days7630 255.2%  
Debtors Days Days9034 267.5%  
Net fixed assets Rs m131,660556 23,667.1%   
Share capital Rs m90378 1,162.4%   
"Free" reserves Rs m134,073878 15,265.0%   
Net worth Rs m134,9761,069 12,622.8%   
Long term debt Rs m56,478159 35,587.8%   
Total assets Rs m266,0732,399 11,089.1%  
Interest coverage x24.27.6 319.0%   
Debt to equity ratio x0.40.1 281.9%  
Sales to assets ratio x0.71.7 37.9%   
Return on assets %10.26.4 158.9%  
Return on equity %18.911.6 163.5%  
Return on capital %19.318.5 104.4%  
Exports to sales %00.8 0.0%   
Imports to sales %01.4 0.0%   
Exports (fob) Rs mNA33 0.0%   
Imports (cif) Rs mNA58 0.0%   
Fx inflow Rs m81,88533 248,889.4%   
Fx outflow Rs m21,50663 34,034.2%   
Net fx Rs m60,378-30 -199,334.4%   
CASH FLOW
From Operations Rs m41,148127 32,502.0%  
From Investments Rs m-25,287-146 17,319.7%  
From Financial Activity Rs m4,33222 19,779.9%  
Net Cashflow Rs m20,1933 807,700.0%  

Share Holding

Indian Promoters % 46.6 65.4 71.3%  
Foreign collaborators % 0.2 0.0 -  
Indian inst/Mut Fund % 11.3 3.7 305.4%  
FIIs % 31.9 5.2 613.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 10.1 25.8 39.1%  
Shareholders   98,259 12,723 772.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare LUPIN LTD With:   ASTRAZENECA PHARMA  DR. DATSONS LABS  ELDER PHARMA  NOVARTIS  PANACEA BIOTECH  

Compare LUPIN LTD With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Day up 260 Points; Pharma Stocks Top Gainers(Closing)

After opening the day in red, share markets in India witnessed positive trading activity throughout the day and ended the day on a positive note.

Related Views on News

TTK HEALTHCARE Announces Quarterly Results (4QFY18); Net Profit Up 43.1%

Jun 14, 2018 | Updated on Jun 14, 2018

For the quarter ended March 2018, TTK HEALTHCARE has posted a net profit of Rs 80 m (up 43.1% YoY). Sales on the other hand came in at Rs 1 bn (up 21.4% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

More Views on News

Most Popular

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

Will You Dump Your Client if You're Busy? Inox Wind's Auditor Just Did...(The 5 Minute Wrapup)

Jun 14, 2018

After Inox Wind, you may see more auditors resigning And the reasons can be as funny as they can get.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Should You Invest In Mirae Asset Healthcare Fund?(Outside View)

Jun 15, 2018

Mirae Asset Mutual Fund launches NFO - Mirae Asset Helathcare Fund.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

LUPIN LTD SHARE PRICE


Jun 22, 2018 (Close)

TRACK LUPIN LTD

  • Track your investment in LUPIN LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

LUPIN LTD - PANACEA BIOTECH COMPARISON

COMPARE LUPIN LTD WITH

MARKET STATS